| 薛载耀,司全金.心力衰竭的诊断与治疗研究进展[J].中国临床保健杂志,2017,20(3):321-325. |
| 心力衰竭的诊断与治疗研究进展 |
| Research progress on in diagnosis and treatment of heart failure |
| 投稿时间：2016-09-26 |
| DOI：10.3969/J.issn.1672-6790.2017.03.032 |
| 中文关键词: 心力衰竭 生物学标记 药物疗法 基因,调节 |
| 英文关键词: Heart failure Biological markers Drug therapy Genes,regulator〖FL |
| 基金项目:海南省自然科学基金(20158267) |
|
| 摘要点击次数: 6869 |
| 全文下载次数: 4466 |
| 中文摘要: |
| 心力衰竭是多种心血管病的终末阶段,病因多种多样,发病机制复杂,在全世界范围内都有很高的死亡率。心力衰竭的患者生活质量受到极大影响,给个人及社会带来重大健康与经济负担。近年来不断的研究结果令人振奋,新的生物标志物可以更好的帮助临床医生诊断和治疗心力衰竭,LCZ696等新药的临床应用也值得期待,射血分数保留的心衰得到了更多的重视,非药物治疗方式的多样化也带来了更多的选择。 |
| 英文摘要: |
| Heart failure is the final stage of multiple cardio diseases,with multiple etiologies,complex pathogenesis,and high mortality rates worldwide.The life quality of patients with heart failure is greatly impacted,bringing significant health and economic burden to individuals and society.In recent years,continuously the research results are encouraging,new biomarkers may help clinicians diagnosis and treatment of heart failure better,LCZ696 and other new drugs are expectant the clinical application,ejection fraction preserved heart failure received more attention,the diversification of non-drug treatment also brings more choice. |
|
查看全文
|
| 关闭 |
|
|
|